Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease (Q27473126)
scientific article
Language:
(P31) (Q13442814)
(P304) 899-909
(P407) (Q1860)
(P433) 3
(P478) 50
(P577) Wednesday, March 1, 2006
(P921) (Q7215)
(Q708693)
(Q154869)
(P1104) 11
(P1433) (Q578004)
(P1476) "Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease" (language: en)
(P2093) Robert B Perni
Susan J Almquist
Randal A Byrn
Gurudatt Chandorkar
Pravin R Chaturvedi
Lawrence F Courtney
Caroline J Decker
Kirk Dinehart
Cynthia A Gates
Scott L Harbeson
Angela Heiser
Gururaj Kalkeri
Elaine Kolaczkowski
Kai Lin
Yu-Ping Luong
B Govinda Rao
William P Taylor
John A Thomson
Roger D Tung
Yunyi Wei
Ann D Kwong
Chao Lin
(P2860) (Q27473320)
(Q27473519)
(Q27621649)
(Q27469634)
(Q27733707)
(Q27486027)
(Q27480287)
(Q27860901)
(Q27860949)
(Q27860561)
(Q27860724)
(Q28370553)
(Q29547886)
(Q29620656)
(Q29614207)
(Q29615896)
(Q29617995)
(Q40425026)
(Q34364260)
(Q40967696)
(Q40882812)
(Q38518078)
(Q40606007)
(Q35205880)
(Q35116376)
(Q34156940)
(Q34551348)
(Q33993109)
(Q39635194)
(Q42985381)
(Q42548481)
(Q42981031)
(Q42994273)
(Q42990950)
(Q45040418)
(Q44984454)
(Q44819208)
(Q42982898)
(Q42981951)
(Q42980953)
(Q45768139)
(Q74230747)
other details
description scientific article

External Links